HSE to breach cost rules to buy new cancer drugs

The HSE is to spend €3.6m a year on new drugs to assist 230 patients with advanced forms of cancer.

Wed, 13 Mar, 2013 - 00:00

Dan Buckley

The decision is in breach of Department of Health cost guidelines but will save or at least prolong lives.

Irish patients will have access to four new cancer drugs this week, following approval by the National Cancer Control Programme (NCCP). The news was welcomed yesterday by the Irish Cancer Society.

CONNECT WITH US TODAY

NEWSLETTERS

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Woman more likely to feel downhearted or depressed than men, new survey shows

Five sites linked to majority of odour complaints as EPA steps up enforcement

New National Childrens Hospital to cost more than 1.43 billion euro

Development board of National Children's Hospital to seek damages due to BAM delays

Courts Person: Susan O’Reilly Person: Gráinne O’Rourke Organisation: HSE Organisation: Department Organisation: National Cancer Control Programme Organisation: NCCP Organisation: Irish Cancer Society Organisation: ICS

<p>IFI is facing a Workplace Relations Commission case brought by former chief executive Francis O’Donnell (pictured), who alleges he was blackmailed by a sitting senator in relation to his suspension in 2002 of the brother of IFI’s former chair, Fintan Gorman.</p>

Inland Fisheries Ireland admits to 'ongoing and uphill struggle' to win back public trust

READ NOW

HSE to breach cost rules to buy new cancer drugs

Inland Fisheries Ireland admits to 'ongoing and uphill struggle' to win back public trust

Lunchtime News

Latest

HSE to breach cost rules to buy new cancer drugs

Continue reading for €5

Inland Fisheries Ireland admits to 'ongoing and uphill struggle' to win back public trust

Lunchtime News

Latest

Most Read